2013
DOI: 10.1039/c3cc46517a
|View full text |Cite
|
Sign up to set email alerts
|

Rescuing recombinant proteins by sequestration into the P22 VLP

Abstract: Here we report the use of a self-assembling protein cage to sequester and solubilize recombinant proteins which are usually trafficked to insoluble inclusion bodies. Our results suggest that protein cages can be used as novel vehicles to rescue and produce soluble proteins that are otherwise difficult to obtain using conventional methods.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
58
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 44 publications
(61 citation statements)
references
References 21 publications
(39 reference statements)
3
58
0
Order By: Relevance
“…431 The strategy for sequestration of enzymes within P22 during expression is also valuable for the recovery of otherwise insoluble proteins. 432 Some recombinant proteins are trafficked to inclusion bodies during production in E. coli , making recovery difficult. α-galactosidase (GalA) is one such protein that was studied, and encapsulation within P22 was shown to allow for successful rescue of properly folded GalA.…”
Section: Applications Of Virus-based Particlesmentioning
confidence: 99%
“…431 The strategy for sequestration of enzymes within P22 during expression is also valuable for the recovery of otherwise insoluble proteins. 432 Some recombinant proteins are trafficked to inclusion bodies during production in E. coli , making recovery difficult. α-galactosidase (GalA) is one such protein that was studied, and encapsulation within P22 was shown to allow for successful rescue of properly folded GalA.…”
Section: Applications Of Virus-based Particlesmentioning
confidence: 99%
“…These viral platforms were intended to be used as imaging probes. Many proteins have also been entrapped within VLPs, such as bacteriophage Qβ [31] and bacteriophage P22 [32][33][34][35][36], in order to solubilize, stabilize and protect them. Protein encapsulation is generally accomplished either by in vitro packaging through disassembly and reassembly of VLPs in the presence of protein cargo or through genetic fusion of the scaffold protein to the cargo.…”
Section: Drug Encapsulation Through Noncovalent Interactionsmentioning
confidence: 99%
“…In some cases the VLP has been shown to enhance the solubility of recombinant proteins that are otherwise localized to inclusion bodies (Patterson et al, 2013a). VLPs have been shown to increase resistance to protease, thermal, and chemical denaturation (Fiedler et al, 2010).…”
Section: Vlps As Metabolic Compartmentsmentioning
confidence: 99%
“…The notable success of single-enzyme encapsulation toward stabilizing and protecting the enzyme cargo suggests that the most ubiquitous application of this technology is toward prolonging the lifespan of enzymes as useful catalysts. In addition the impressive ability to recover insoluble enzymes or notoriously unstable enzymes by sequestration in a VLP suggests that single-enzyme encapsulation for improved kinetics is best directed at the notoriously hard to handle enzymes and not at the well-behaved model enzymes that have dominated studies thus far (Jordan et al, 2016; Patterson et al, 2013). Additional potential for kinetic enhancement rests in the ability to encapsulate multiple, sequential enzymes in the same capsid.…”
Section: Vlps As Metabolic Compartmentsmentioning
confidence: 99%